title: Immunosuppression conversion for relief of side effects.
authors.affiliation: Mount Sinai Hospital, New York, New York 10029.
authors.forename: S
authors.initials: S
authors.lastname: Guy
authors.forename: E
authors.initials: E
authors.lastname: Mor
authors.forename: A
authors.initials: A
authors.lastname: Fisher
authors.forename: M
authors.initials: M
authors.lastname: Schwartz
authors.forename: P
authors.initials: P
authors.lastname: Sheiner
authors.forename: S
authors.initials: S
authors.lastname: Emre
authors.forename: C
authors.initials: C
authors.lastname: Miller
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D016572:Cyclosporine; D016559:Tacrolimus